Johnson & Johnson (JNJ) Revenue (2009 - 2026)
Johnson & Johnson's Revenue was $25.4 billion in Q3 2026, up 5.9% from $23.99 billion a year earlier and up 0.4% from the prior quarter.
Johnson & Johnson (JNJ) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Johnson & Johnson's Revenue was $99.34 billion through Sep 27, 2026, up 7.8% year-over-year; for FY2025, it came in at $94.19 billion, up 6.0% from FY2024.
- Revenue has now increased for three consecutive years, with a four-year compound annual growth rate of 3.3% (FY2021 to FY2025).
- In earlier years, Revenue was $88.82 billion in FY2024 (+4.3%), $85.16 billion in FY2023 (+6.5%), $79.99 billion in FY2022 and $82.58 billion in FY2021.
- The Q3 2026 figure marks the highest quarterly Revenue in data going back to Q4 2011.
- Compared with a year earlier, Revenue has increased for 12 straight quarters, with growth averaging 6.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Revenue ranged from 2.3% (Q1 2024) to 9.9% (Q1 2026).
- Per Business Quant data, JNJ's Revenue in the three quarters before Q3 2026 was $25.31 billion (Q2 2026), $24.06 billion (Q1 2026) and $24.56 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.24 Bn | 1,117.83 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 636.01 Bn | 555.87 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 500.63 Bn | 473.74 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 357.88 Bn | 312.26 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 301.63 Bn | 265.62 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.02 Bn | 238.70 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 238.20 Bn | 193.60 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.85 Bn | 169.05 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.94 Bn | 118.58 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vertex Pharmaceuticals | 133.81 Bn | 105.82 Bn | 2.84 Bn | 3.33 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 25.40 Bn |
| Jun 28, 2026 | 25.31 Bn |
| Mar 29, 2026 | 24.06 Bn |
| Dec 28, 2025 | 24.56 Bn |
| Sep 28, 2025 | 23.99 Bn |
| Jun 29, 2025 | 23.74 Bn |
| Mar 30, 2025 | 21.89 Bn |
| Dec 29, 2024 | 22.52 Bn |
| Sep 29, 2024 | 22.47 Bn |
| Jun 30, 2024 | 22.45 Bn |
| Mar 31, 2024 | 21.38 Bn |
| Dec 31, 2023 | 21.40 Bn |
| Oct 1, 2023 | 21.35 Bn |
| Jul 2, 2023 | 21.52 Bn |
| Apr 2, 2023 | 20.89 Bn |
| Jan 1, 2023 | 19.94 Bn |
| Oct 2, 2022 | 20.00 Bn |
| Jul 3, 2022 | 20.22 Bn |
| Apr 3, 2022 | 19.84 Bn |
| Oct 3, 2021 | 23.34 Bn |
Johnson & Johnson Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();